https://www.news-medical.net/news/20230112/New-CRISPR-Cas9-approach-confers-protection-from-ischemiareperfusion-injury.aspx
A new CRISPR-Cas9 approach that targets a detrimental signaling pathway in the heart confers protection from ischemia/reperfusion injury, according to a study in mice.
Create an account or login to join the discussion